UPDATE: Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Neutral
Tweet Send to a Friend
(Updated - June 16, 2016 8:42 AM EDT)
Chardan Capital Markets upgraded Arbutus Biopharma (NASDAQ: ABUS) from Sell to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Chardan Capital Markets upgraded Arbutus Biopharma (NASDAQ: ABUS) from Sell to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
